Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design.

Journal Information

Full Title: Ann Am Thorac Soc

Abbreviation: Ann Am Thorac Soc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Author disclosures are available with the text of this article at www.atsjournals.org."

Evidence found in paper:

"Supported by the Cystic Fibrosis Foundation (CFF) (funding for the SIMPLIFY study). N.M.-H. was supported by the CFF grant HAMBLE20K0 and U.S. National Institutes of Health (NIH) grants P30 DK 089507 and UL1 TR002319. D.P.N. was supported by CFF grant NICHOL20K0 and NIH grants P30 DK 089507 and 5RO1HL124053. A.H.G. was supported by the CFF (SIMPLIFY-GIFFOR20K0 and GIFFOR17Y5) and NIH grant P30 DK 117469. K.A.R. was supported by the CFF grant RIEKER15PE0. G.S.S. was supported by the CFF grant SAWIC15PE0. M.W.K. was supported by the CFF and NIH grants UL1 TR002548 and P01 HL128192. G.R.-B. was supported by CFF grant RETSCH08Y3."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025